Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury

Journal of Pineal Research

Volumn 46, Issue 1, 2009, Pages 79-86

  Esposito, Emanuela ^a,b   Genovese, Tiziana ^b   Caminiti, Rocco ^c   Bramanti, Placido ^b   Meli, Rosaria ^a   Cuzzocrea, Salvatore ^b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Free radicals; Inflammation; Protein kinase signaling; Spinal cord injury

Indexed keywords

MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LAMINECTOMY; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PINEAL BODY; PROTEIN EXPRESSION; SPINAL CORD INJURY; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; INJURY SCALE; METABOLISM; MOTOR NEURON DISEASE; PHYSIOLOGICAL STRESS; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

ANALYSIS OF VARIANCE; ANIMALS; HMGB1 PROTEIN; INTERLEUKIN-1BETA; MAP KINASE SIGNALING SYSTEM; MELATONIN; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MOTOR NEURON DISEASE; SPINAL CORD INJURIES; STRESS, PHYSIOLOGICAL; TRAUMA SEVERITY INDICES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57149142404     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00633.x     Document Type: Article

References (61)

1. Maegele M, Riess P, Sauerland S et al. Characterization of a new rat model of experimental combined neurotrauma. Shock 2005 23 : 476 481.
2. Profyris C, Cheema SS, Zang D et al. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 2004 15 : 415 436.
3. Batchelor PE, Porritt MJ, Martinello P et al. Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol Cell Neurosci 2002 21 : 436 453.
4. Genovese T, Mazzon E, Crisafulli C et al. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 2006 316 : 1006 1016.
5. Park E, Velumian AA, Fehlings MG. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 2004 21 : 754 774.
6. Bhat NR, Zhang P, Lee JC et al. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 1998 18 : 1633 1641.
7. Wang MJ, Jeng KC, Kuo JS et al. C-jun n-terminal kinase and, to a lesser extent, p38 mitogen-activated protein kinase regulate inducible nitric oxide synthase expression in hyaluronan fragments-stimulated bv-2 microglia. J Neuroimmunol 2004 146 : 50 62.
8. Xie Z, Smith CJ, Van Eldik LJ. Activated glia induce neuron death via map kinase signaling pathways involving jnk and p38. Glia 2004 45 : 170 179.
9. Pouyssegur J. Signal transduction. An arresting start for mapk. Science (New York, NY) 2000 290 : 1515 1518.
10. Kamata H, Honda S, Maeda S et al. Reactive oxygen species promote tnfalpha-induced death and sustained jnk activation by inhibiting map kinase phosphatases. Cell 2005 120 : 649 661.
11. Handley ME, Thakker M, Pollara G et al. Jnk activation limits dendritic cell maturation in response to reactive oxygen species by the induction of apoptosis. Free Radic Biol Med 2005 38 : 1637 1652.
12. Wang H, Bloom O, Zhang M et al. Hmg-1 as a late mediator of endotoxin lethality in mice. Science (New York, NY) 1999 285 : 248 251.
13. Lotze MT, Tracey KJ. High-mobility group box 1 protein (hmgb1): nuclear weapon in the immune arsenal. Nat Rev 2005 5 : 331 342.
14. Yang H, Wang H, Czura CJ et al. The cytokine activity of hmgb1. J Leukoc Biol 2005 78 : 1 8.
15. Abraham E, Arcaroli J, Carmody A et al. Hmg-1 as a mediator of acute lung inflammation. J Immunol 2000 165 : 2950 2954.
16. Sappington PL, Yang R, Yang H et al. Hmgb1 b box increases the permeability of caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002 123 : 790 802.
17. Hardeland R, Backhaus C, Fadavi A. Reactions of the no redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite n1-acetyl-5-methoxykynuramine. J Pineal Res 2007 43 : 382 388.
18. Tan DX, Manchester LC, Hardeland R et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003 34 : 75 78.
19. Manda K, Ueno M, Anzai K. Afmk, a melatonin metabolite, attenuates x-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007 42 : 386 393.
20. Gilad E, Cuzzocrea S, Zingarelli B et al. Melatonin is a scavenger of peroxynitrite. Life Sci 1997 60 : PL169 PL174.
21. Cuzzocrea S, Zingarelli B, Gilad E et al. Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J Pineal Res 1997 23 : 106 116.
22. Stasica P, Ulanski P, Rosiak JM. Melatonin as a hydroxyl radical scavenger. J Pineal Res 1998 25 : 65 66.
23. Leon J, Escames G, Rodriguez MI et al. Inhibition of neuronal nitric oxide synthase activity by n1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem 2006 98 : 2023 2033.
24. Cuzzocrea S, Tan DX, Costantino G et al. The protective role of endogenous melatonin in carrageenan-induced pleurisy in the rat. FASEB J 1999 13 : 1930 1938.
25. Genovese T, Mazzon E, Crisafulli C et al. Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma. J Pineal Res 2007 43 : 140 153.
26. Genovese T, Mazzon E, Muia C et al. Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin. J Pineal Res 2005 38 : 198 208.
27. Bethea JR, Castro M, Keane RW et al. Traumatic spinal cord injury induces nuclear factor-kappab activation. J Neurosci 1998 18 : 3251 3260.
28. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995 12 : 1 21.
29. Joshi M, Fehlings MG. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J Neurotrauma 2002 19 : 191 203.
30. Joshi M, Fehlings MG. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma 2002 19 : 175 190.
31. Genovese T, Mazzon E, Mariotto S et al. Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J Neurosurg Spine 2006 4 : 145 153.
32. Bao F, Dewitt DS, Prough DS et al. Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: reduction by mn (iii) tetrakis (4-benzoic acid) porphyrin. J Neurosci Res 2003 71 : 220 227.
33. Cuzzocrea S, Genovese T, Mazzon E et al. Poly(adp-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma. J Pharmacol Exp Ther 2006 319 : 127 138.
34. Glaser J, Gonzalez R, Sadr E et al. Neutralization of the chemokine cxcl10 reduces apoptosis and increases axon sprouting after spinal cord injury. J Neurosci Res 2006 84 : 724 734.
35. Kalkan E, Cicek O, Unlu A et al. The effects of prophylactic zinc and melatonin application on experimental spinal cord ischemia-reperfusion injury in rabbits: experimental study. Spinal Cord 2007 45 : 722 730.
36. Liu JB, Tang TS, Yang HL et al. Antioxidation of melatonin against spinal cord injury in rats. Chin J Traumatol 2004 117 : 571 575.
37. Samantaray S, Sribnick EA, Das A et al. Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res 2008 44 : 348 357.
38. Tator CH. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie 1991 37 : 291 302.
39. Anderson DK, Hall ED. Pathophysiology of spinal cord trauma. Ann Emerg Med 1993 22 : 987 992.
40. Anderson KD, Gunawan A, Steward O. Spinal pathways involved in the control of forelimb motor function in rats. Exp Neurol 2007 206 : 318 331.
41. Wick A, Wick W, Waltenberger J et al. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and akt. J Neurosci 2002 22 : 6401 6407.
42. Xu Z, Wang BR, Wang X et al. Erk1/2 and p38 mitogen-activated protein kinase mediate inos-induced spinal neuron degeneration after acute traumatic spinal cord injury. Life Sci 2006 79 : 1895 1905.
43. Nakahara S, Yone K, Sakou T et al. Induction of apoptosis signal regulating kinase 1 (ask1) after spinal cord injury in rats: possible involvement of ask1-jnk and -p38 pathways in neuronal apoptosis. J Neuropathol Exp Neurol 1999 58 : 442 450.
44. Jin K, Sun Y, Xie L et al. Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiol Dis 2005 18 : 366 374.
45. Bonetti B, Stegagno C, Cannella B et al. Activation of nf-kappab and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. Am J Pathol 1999 155 : 1433 1438.
46. Combs CK, Karlo JC, Kao SC et al. Beta-amyloid stimulation of microglia and monocytes results in tnfalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 2001 21 : 1179 1188.
47. Choi SH, Joe EH, Kim SU et al. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci 2003 23 : 5877 5886.
48. Genovese T, Esposito E, Mazzon E et al. Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury. J Pharmacol Exp Ther 2008 325 : 100 114.
49. Streit WJ, Semple-Rowland SL, Hurley SD et al. Cytokine mrna profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 1998 152 : 74 87.
50. Rendon-Mitchell B, Ochani M, Li J et al. Ifn-gamma induces high mobility group box 1 protein release partly through a tnf-dependent mechanism. J Immunol 2003 170 : 3890 3897.
51. Tang D, Shi Y, Jang L et al. Heat shock response inhibits release of high mobility group box 1 protein induced by endotoxin in murine macrophages. Shock (Augusta, GA) 2005 23 : 434 440.
52. Wang H, Vishnubhakat JM, Bloom O et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999 126 : 389 392.
53. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein hmgb1 by necrotic cells triggers inflammation. Nature 2002 418 : 191 195.
54. Rovere-Querini P, Capobianco A, Scaffidi P et al. Hmgb1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004 5 : 825 830.
55. Messmer D, Yang H, Telusma G et al. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and th1 polarization. J Immunol 2004 173 : 307 313.
56. Dumitriu IE, Baruah P, Bianchi ME et al. Requirement of hmgb1 and rage for the maturation of human plasmacytoid dendritic cells. Eur J Immunol 2005 35 : 2184 2190.
57. Dumitriu IE, Baruah P, Valentinis B et al. Release of high mobility group box 1 by dendritic cells controls t cell activation via the receptor for advanced glycation end products. J Immunol 2005 174 : 7506 7515.
58. Tang D, Shi Y, Kang R et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release hmgb1. J Leukoc Biol 2007 81 : 741 747.
59. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
60. Reiter RJ, Tan DX, Poeggeler B et al. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann N Y Acad Sci 1994 719 : 1 12.
61. Aydogan S, Yerer MB, Goktas A. Melatonin and nitric oxide. J Endocrinol Invest 2006 29 : 281 287.